Hepatic cytolysis and bicytopenia after 15 days of four-drug tuberculosis treatment in Senegal

K Thiam; J M A N Sagne; E H M Ndiaye; M F Cissé; F B R Mbaye; N O Touré; Y Dia Kane; A Diatta; S Niang; U D Kombila; S Dia; M Ndao; W Ka

doi:10.1684/mst.2017.0714

Hepatic cytolysis and bicytopenia after 15 days of four-drug tuberculosis treatment in Senegal

Med Sante Trop. 2017 Aug 1;27(3):233-234. doi: 10.1684/mst.2017.0714.

Authors

K Thiam¹, J M A N Sagne¹, E H M Ndiaye¹, M F Cissé¹, F B R Mbaye¹, N O Touré¹, Y Dia Kane¹, A Diatta¹, S Niang¹, U D Kombila¹, S Dia¹, M Ndao¹, W Ka¹

Affiliation

¹ Clinique de pneumo-phtisiologie du CHNU de Fann, 12566 Dakar, Sénégal.

PMID: 28947398
DOI: 10.1684/mst.2017.0714

Abstract

We report the case of a 31-year-old immunocompetent woman residing in Senegal, with localized microscopy-proved pulmonary tuberculosis, complicated by macrophage activation syndrome and associated with viral hepatitis B, identified due to hepatic cytolysis and a bicytopenia.

Keywords: Senegal; bicytopenia; hemophagocytosis; hepatic cytolysis; pulmonary tuberculosis.

Publication types

Case Reports

MeSH terms

Adult
Antitubercular Agents / administration & dosage*
Drug Therapy, Combination
Female
Humans
Liver Diseases / etiology*
Liver Diseases / pathology*
Macrophage Activation Syndrome / etiology*
Senegal
Time Factors
Tuberculosis, Pulmonary / complications*
Tuberculosis, Pulmonary / drug therapy*

Substances

Antitubercular Agents